Finance News Network Interview, 12. Nov. 2018, Immutep Limited (ASX:IMM) Executive Director and CEO, Marc Voigt provides an update on the company's clinical trials, collaboration with large pharma and key milestones.

Your Money - Interview with Marc Voigt (Executive Director and CEO), 31. Oct. 2018

Finance News Network - Interview with Marc Voigt (Executive Director and CEO), 06. Sept. 2018

Brand movie - bringing new hope to patients

FNN – Interview with Immutep

Sky Business News - Interview with Marc Voigt (Executive Director and CEO), 30. April 18

Interview with Frédéric Triebel /CSO & CMO) & Marc Voigt (Executive Director and CEO)

CNBC - Interview with Marc Voigt (Executive Director and CEO)

Mode of Action of eftilagimod alpha (“IMP321”)

Sky Business News - Interview with Marc Voigt (Executive Director and CEO), 25. Nov. 15

The Business - Interview with Lucy Turnbull

Sky Business News - Interview with Marc Voigt (Executive Director and CEO), 16. May 2014

Webcasts

Give it a listen.